Randomized, dose-escalation study of the p38α MAPK inhibitor SCIO-469 in patients with myelodysplastic syndrome
2012; Springer Nature; Volume: 27; Issue: 4 Linguagem: Inglês
10.1038/leu.2012.264
ISSN1476-5551
AutoresLubomir Sokol, Larry D. Cripe, Hagop M. Kantarjian, Mikkael A. Sekeres, Simrit Parmar, Peter L. Greenberg, Steven L. Goldberg, Vikas Bhushan, Jamile M. Shammo, Raymond J. Hohl, Amit Verma, Guillermo Garcia‐Manero, Y. P. Li, Alarice Lowe, Jaja Zhu, Alan F. List,
Tópico(s)Histone Deacetylase Inhibitors Research
ResumoRandomized, dose-escalation study of the p38α MAPK inhibitor SCIO-469 in patients with myelodysplastic syndrome
Referência(s)